PROSTATE CANCER IMMUNOTHERAPY BY TARGETING DENDRITIC CELLS IN VIVO USING RECEPTOR-SPECIFIC APTAMER CONJUGATED TO PROSTATE STEM CELL ANTIGEN (PSCA)-EN

Duke University, Durham NC

Investigators